홈 > 시장보고서 > 의료기기 > 약물전달기기

시장보고서

상품코드

1280670

후버니들 시장 규모, 시장 점유율, 용도 분석, 지역별 전망, 성장 동향, 주요 기업, 경쟁 전략, 예측(2023-2031년)

Huber Needles Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

발행일: 2023년 05월 | 리서치사:

Acute Market Reports | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

후버니들은 수혈, 화학요법, 약물전달, 비경구영양, 혈관성형술과 같은 외과적 시술, 조영제 CT 스캔과 같은 진단적 시술 등 다양한 용도로 사용되고 있습니다. 이러한 폭넓은 용도는 세계 후버니들 시장을 주도하고 있습니다. 세계에서 암의 유병률이 높아짐에 따라 화학요법 시행률이 높아지면서 후버니들 수요가 증가하고 있음을 알 수 있습니다. 국제암연구소(IARC)에 따르면 2030년까지 암 발병률은 2170만 명으로 증가할 것으로 예상됩니다. 또한 세계에서 전염병이 유행하면서 수혈 횟수도 증가하고 있습니다. 또한 혈액과 혈액제제의 필요성에 대한 인식이 높아지고 헌혈에 대한 의지가 높아지면서 헌혈 비율도 증가하고 있습니다. 세계보건기구(WHO)는 2017년 한 해 동안 세계에서 약 1억 1,250만 건의 헌혈이 이루어졌습니다고 발표했습니다.

진단 기술의 발전도 후버니들 부문의 장점에 기여하고 있습니다. 예를 들어 조영제 CT 검사는 특수한 조영제를 정맥으로 주입해야 합니다. 이러한 진단 검사는 암과 만성질환 증가와 함께 지속적으로 증가하고 있으며, 전체 시장 성장에 기여하고 있습니다. 각 제조업체들은 환자의 안전 요구에 부응하는 첨단 제품을 개발하기 위한 연구 활동을 지속적으로 진행하고 있습니다. 미국 식품의약국(FDA)의 후버니들 안티코어링 테스트 도입은 환자의 안전을 보장하기 위해 그 수요를 더욱 증가시키고 있습니다.

후버니들 제품 유형에는 직선형, 곡선형 등이 있는데, 예측 기간 중 시장 성장이 기대되는 것은 곡선형입니다. 비경구 영양제 및 약물 투여, 화학 요법에 활용되고 있습니다. 곡선형 테마 키보드는 주입한 곳에 며칠 동안 방치할 수 있으므로 직선형 테마 키보드처럼 정기적인 교체가 필요하지 않습니다.

북미는 암, 만성질환, 헌혈 증가로 인해 지역별 시장으로 우위를 점할 것으로 보입니다. 또한 진단율 향상, 의료 인프라 개선, 주사바늘에 대한 환급 제도 등이 전체 시장 성장에 기여하고 있습니다. 그러나 후버니들 비용 상승, 코링의 위험, 감염으로 이어지는 오염은 전체 시장 성장에 부정적인 영향을 미칠 수 있습니다.

시장 개요
후버니들 시장 : 제품별 2021-2031
후버니들 시장 : 애플리케이션별 2021-2031
후버니들 시장 : 최종사용자별 2021-2031
후버니들 시장 : 지역별 2021-2031
- 영국과 유럽연합
  - 영국
  - 독일
  - 스페인
  - 이탈리아
  - 프랑스
  - 기타 유럽 지역

제10장 아시아태평양의 후버니들 시장 2021-2031

시장 개요
후버니들 시장 : 제품별 2021-2031
후버니들 시장 : 애플리케이션별 2021-2031
후버니들 시장 : 최종사용자별 2021-2031
후버니들 시장 : 지역별 2021-2031
- 아시아태평양
  - 중국
  - 일본
  - 인도
  - 호주
  - 한국
  - 기타 아시아태평양

제11장 라틴아메리카의 후버니들 시장 2021-2031

시장 개요
후버니들 시장 : 제품별 2021-2031
후버니들 시장 : 애플리케이션별 2021-2031
후버니들 시장 : 최종사용자별 2021-2031
후버니들 시장 : 지역별 2021-2031
- 라틴아메리카
  - 브라질
  - 멕시코
  - 기타 라틴아메리카 지역

제12장 중동 및 아프리카의 후버니들 시장 2021-2031

시장 개요
후버니들 시장 : 제품별 2021-2031
후버니들 시장 : 애플리케이션별 2021-2031
후버니들 시장 : 최종사용자별 2021-2031
후버니들 시장 : 지역별 2021-2031
- 중동 및 아프리카
  - GCC
  - 아프리카
  - 기타 중동 및 아프리카

제13장 기업 개요

AngioDynamics Inc.
B. Braun Medical Inc.
Baxter International Inc.
C.R. Bard Inc.
Exel International Inc.
Medsurg
NIPRO Medical Corporations
Novo Nordsik
Smiths Medical Inc.
Thiebaud S.A.S.
Vygon S.A.
기타

KSA 23.06.15

Huber needles find wide application in blood transfusions, chemotherapy, drug delivery, parenteral nutrition, surgical procedures such as angioplasty and diagnostic procedures such as contrast CT scans. Therefore wide application areas predominantly drive the Huber needles market globally. Growing prevalence of cancer across the globe increases the rate of chemotherapy administration, indicating higher demand for Huber needles. As per the International Agency for Research on Cancer (IARC), cancer is expected to increase to 21.7 million by 2030. With increasing prevalence of infectious diseases across the globe, number of blood transfusions have also risen. The rate of blood donations have also increased with growing awareness on need for blood and blood products, and rising willingness of people to donate. The World Health Organization (WHO) states that around 112.5 million blood donations were carried out globally, as per 2017 review.

Advancement in diagnostic techniques has also contributed to the lucrativeness of Huber needles segment. For instance, contrast CT scans require injecting of special intravenous contrast dye. The number of such diagnostic tests keeps on increasing with growing prevalence of cancer and chronic diseases, thus contributing to the overall market growth. Manufacturers are continuously carrying out research activities in developing advanced products catering to patient's safety requirements. Introduction by the Food and Drug Administration (FDA) of anti-coring test for Huber needles ensures patient safety thus further raising its demand.

Of the product types available in the market such as, straight and curved Huber needles, curved Huber needles are said to highlight potential market growth during the forecast period. They are utilised to deliver parenteral nutrition, medications and in certain chemotherapy regimens. Curved Huber needles can be left in injected place for few days, therefore without requiring periodic change as seen in straight Huber needles.

North America is likely to emerge as dominant regional market owing to rise in prevalence of cancer, chronic diseases and blood donations. Additionally, growth in diagnosis rate, developed healthcare infrastructure and provision of reimbursement for needles contribute to the overall market growth. However, rising cost of Huber needles, and the risk of coring and contamination leading to infections could have a negative impact on the overall market growth.

Global market outreach and key players:

The Huber needles market comprises a competitive pool of many market leaders. Huber needles are globally available with presence of multiple manufacturers across geographies. Key players having vast market outreach are AngioDynamics, Inc., B. Braun Medical Inc., Baxter International Inc., C.R. Bard, Inc., Exel International, Inc., Medsurg, NIPRO Medical Corporations, Novo Nordsik, Smiths Medical, Inc., Thiebaud S.A.S., Vygon S.A. And Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Huber Needles market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Huber Needles market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Straight Huber Needles
Curved Huber Needles

Application

Transfusion of Blood
Application for Cancer
Parental Nutrition
Others

End user

Hospitals
Clinics
Ambulatory surgical centers
Others

Region Segment (2021-2031; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Huber Needles market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Huber Needles market?

Which is the largest regional market for Huber Needles market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Huber Needles market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Huber Needles market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Huber Needles Market
2.2. Global Huber Needles Market, By Product, 2022 (US$ Million)
2.3. Global Huber Needles Market, By Application, 2022 (US$ Million)
2.4. Global Huber Needles Market, By End user, 2022 (US$ Million)
2.5. Global Huber Needles Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Huber Needles Market: Competitive Analysis

3.1. Market Positioning of Key Huber Needles Market Vendors
3.2. Strategies Adopted by Huber Needles Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Huber Needles Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Huber Needles Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Huber Needles Market: By Product, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Straight Huber Needles
- 5.3.2. Curved Huber Needles

6. Huber Needles Market: By Application, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Transfusion of Blood
- 6.3.2. Application for Cancer
- 6.3.3. Parental Nutrition
- 6.3.4. Others

7. Huber Needles Market: By End user, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Ambulatory surgical centers
- 7.3.4. Others

8. North America Huber Needles Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
8.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
8.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
8.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)

9. UK and European Union Huber Needles Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
9.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
9.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
9.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.4.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.4.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.5.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.5.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.6.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.6.1. Huber Needles Market: By End user, 2021-2031, USD (Million)

10. Asia Pacific Huber Needles Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
10.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
10.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
10.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.4.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.4.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.5.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.5.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.6.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.6.1. Huber Needles Market: By End user, 2021-2031, USD (Million)

11. Latin America Huber Needles Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
11.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
11.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
11.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)

12. Middle East and Africa Huber Needles Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
12.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
12.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
12.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)

13. Company Profile

13.1. AngioDynamics, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. B. Braun Medical Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. Baxter International Inc.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. C.R. Bard, Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. Exel International, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. Medsurg
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. NIPRO Medical Corporations
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Novo Nordsik
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. Smiths Medical, Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. Thiebaud S.A.S.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Vygon S.A.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격